Drug Research
Most Studied Diseases List Has Breast Cancer At The Top
Oncology research has gone on to attain priority status and has apparently been flush with pharma research dollars for years. The fact is that drug development companies went on to raise $7 billion in 2020 because of the disease’s...
News
Medicines For Europe Seeking Easier SPC Manufacturing Waiver
As per Medicines for Europe, the Munich District Court’s Supplementary Protection Certificate- SPC manufacturing waiver, which was issued in Germany in October last year, happens to be in conflict with the objectives of the waiver.
The organization as well as...
Drug Research
Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release
Cresset, a provider of integrated in silico solutions for drug discovery, has released the latest version of its Flare drug discovery platform, which aims to improve ligand and structure-based drug design and the lead optimization process in early drug...
News
Pistoia Alliance launches freely available IDMP Ontology 1.0, covering all five standards set by ISO
The Pistoia Alliance, a global not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has published its Identification of Medicinal Products (IDMP) Ontology 1.0 under an open-source license. The Pistoia Alliance plans to support the implementation of...
News
FDA To Launch Largest Reorganization In History This Year
It is well to be noted that a proposed FDA reorganization might as well have food safety first and foremost; however, stakeholders throughout industries will go on to feel the effects of what Michael Rogers, associate commissioner for regulatory...
Drug Research
Single-Use Systems To Push Growth of E&L Testing Market
The worldwide extractable and leachable- E&L testing services market is all set to value $2.57 million by 2030, as per the latest report by ResearchAndMarkets. Between 2023 and 2030, this goes on to represent a CAGR of 15.13%, as...
News
Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion
Bora Pharmaceuticals Co., Ltd announced that its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer based in Minnesota, US, from shareholders, Sawai Group Holdings Co., Ltd. , and Sumitomo Corporation of Americas, for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read